| 
 
 Invited Speaker
 Protection Against Pathogen 
            Infection By Boosting Host Innate Immunity
 Goutam Gupta
 USA
 
 Innate immune system is the first line of host defense against the 
            invading pathogens. It has been conserved through evolution across 
            plants, insects, and humans. The abilities of the host to first recognize 
            and then to clear the pathogen are the two essential steps of the 
            innate immune defense. This allows rapid elimination of the pathogen 
            before it can establish infection in the host and cause disease. However, 
            many pathogens have developed resistance either by blocking the recognition 
            or the clearance step of the host innate immune process. We have developed 
            a strategy that overcomes pathogenic resistance against host innate 
            immune defense. The strategy involves the design of a protein chimera 
            in which the functional domains for pathogen recognition and clearance 
            are linked together in the same protein. The feasibility of this approach 
            has been successfully tested against Xylella fastidiosa that is transmitted 
            by sharpshooter vectors in the plant xylem and causes diseases in 
            many economically important plants. The most notable diseases are: 
            Pierce’s Disease in grapes and Variegated Chlorosis in citrus. 
            We have been able to generate a transgenic grape line that produces 
            the chimeric protein in the plant xylem (the very site of infection) 
            and completely protects against Xylella fastidiosa infection. This 
            is the first example in which a chimeric protein is expressed locally 
            at the site of infection in a transgenic plant to protect against 
            pathogen infection. A similar strategy has also been successful in 
            vitro for protection against staphylococcal infection (a human pathogen). 
            The possibility of converting our strategy into a universal therapy 
            against viral, bacterial, and fungal pathogens seems logical and appealing.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 |